Clinical Trial Update: Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial is evaluating serum glycomics as prognostic and diagnostic biomarkers for recurrence of hepatocellular carcinoma in liver transplant recipients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prognostic Biomarker, Liver Transplantation | Status: RECRUITING